Syneos Health General and Administrative Expenses 2011-2026 | SYNH

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Syneos Health

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
571 M	442 M	446 M	406 M	283 M	172 M	157 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
571 M	157 M	354 M

Quarterly General and Administrative Expenses Syneos Health

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
162 M	-	-	-	140 M	-	140 M	145 M	137 M	-	118 M	108 M	126 M	-	110 M	111 M	113 M	-	96.9 M	100 M	99.3 M	-	88.9 M	42.5 M	44.9 M	-	41.7 M	42.6 M	43.5 M	-	40.4 M	37.1 M	35.8 M	-	38.2 M	34 M	32.2 M	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
162 M	32.2 M	85.7 M

General and Administrative Expenses of other stocks in the Diagnostics research industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	46.7 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	1.62 B	$ 113.86	-0.85 %	$ 34.6 B	USA
Danaher Corporation DHR	8.24 B	$ 190.59	-0.8 %	$ 136 B	USA
DexCom DXCM	1.29 B	$ 63.64	0.68 %	$ 24.8 B	USA
Fulgent Genetics FLGT	88.1 M	$ 16.32	-0.61 %	$ 493 M	USA
Guardant Health GH	211 M	$ 90.59	1.04 %	$ 11.4 B	USA
ICON Public Limited Company ICLR	585 M	$ 107.81	-1.66 %	$ 8.89 B	Irlanda
Illumina ILMN	1.09 B	$ 127.23	-0.4 %	$ 20.2 B	USA
CareDx, Inc CDNA	108 M	$ 17.63	-1.07 %	$ 939 M	USA
Oxford Immunotec Global PLC OXFD	22.3 M	-	-	$ 562 M	Britain
Laboratory Corporation of America Holdings LH	2.22 B	$ 274.85	0.14 %	$ 22.9 B	USA
Lantheus Holdings LNTH	275 M	$ 75.68	-0.28 %	$ 5.11 B	USA
Akumin AKU	2.08 M	-	-17.87 %	$ 25.9 M	Canada
Medpace Holdings MEDP	198 M	$ 493.63	-0.48 %	$ 14.2 B	USA
Burning Rock Biotech Limited BNR	490 M	$ 16.99	4.23 %	$ 176 M	China
Myriad Genetics MYGN	257 M	$ 4.62	-1.07 %	$ 428 M	USA
Co-Diagnostics CODX	9.06 M	$ 4.4	101.83 %	$ 5.85 M	USA
NeoGenomics NEO	273 M	$ 7.98	-0.5 %	$ 1.02 B	USA
Aspira Women's Health AWH	7.96 M	-	-6.19 %	$ 10.5 M	USA
Neogen Corporation NEOG	218 M	$ 9.93	3.82 %	$ 2.15 B	USA
Natera NTRA	589 M	$ 207.69	1.38 %	$ 20.4 B	USA
Accelerate Diagnostics AXDX	39.2 M	-	-61.36 %	$ 2.46 M	USA
National Research Corporation NRC	54.8 M	$ 17.24	-0.52 %	$ 386 M	USA
Pacific Biosciences of California PACB	141 M	$ 1.4	-1.76 %	$ 420 M	USA
Global Cord Blood Corporation CO	187 M	-	-	$ 399 M	China
Fluidigm Corporation FLDM	97.9 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	3.83 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	126 M	-	0.12 %	$ 80.1 M	China
Precipio PRPO	9.45 M	$ 26.0	0.08 %	$ 41.7 M	USA
Personalis PSNL	46.2 M	$ 6.21	-5.57 %	$ 368 M	USA
Charles River Laboratories International CRL	743 M	$ 167.8	-0.25 %	$ 8.32 B	USA
PRA Health Sciences, Inc. PRAH	453 M	-	-	$ 10.7 B	USA
Sotera Health Company SHC	253 M	$ 14.86	-0.1 %	$ 4.22 B	USA
Castle Biosciences CSTL	200 M	$ 24.96	0.93 %	$ 693 M	USA
Soleno Therapeutics SLNO	132 M	$ 52.25	-	$ 2.66 B	USA
Biocept BIOC	16.1 M	-	-13.05 %	$ 7.29 M	USA
Neuronetics STIM	31.5 M	$ 1.6	-9.09 %	$ 106 M	USA
Biodesix BDSX	80.5 M	$ 14.71	-4.21 %	$ 1.91 B	USA
Koninklijke Philips N.V. PHG	599 M	$ 26.99	-0.79 %	$ 20 B	Niderland
Thermo Fisher Scientific TMO	8.73 B	$ 483.56	-0.95 %	$ 182 B	USA
Trinity Biotech plc TRIB	24.7 M	$ 0.61	-1.34 %	$ 61.9 M	Irlanda
VolitionRx Limited VNRX	9.46 M	$ 0.17	-0.89 %	$ 21.4 M	Singapore
Waters Corporation WAT	240 M	$ 301.9	-0.72 %	$ 18 B	USA
QIAGEN N.V. QGEN	128 M	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	6.63 M	$ 2.59	-	$ 84.1 K	USA
Biomerica BMRA	2.98 M	$ 2.08	-4.13 %	$ 4.78 M	USA
BioNano Genomics BNGO	35.2 M	$ 1.14	-1.3 %	$ 6.21 M	USA
Interpace Biosciences IDXG	9.48 M	$ 2.02	2.54 %	$ 8.94 M	USA
Check-Cap Ltd. CHEK	9.46 M	-	-	$ 9.42 M	Israel
Celcuity CELC	27.2 M	$ 113.87	-0.31 %	$ 5.32 B	USA